Enfermedades respiratorias de origen ocupacional

Archivos de Bronconeumologia

Volumn 36, Issue 11, 2000, Pages 631-644

  Martinez Gonzalez C ^a,b   Rego Fernandez G ^a  

^a HOSPITAL UNIVERSITARIO CENTRAL DE ASTURIAS   (Spain)

^b Instituto Nacional de Silicosis   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

ALGORITHM; HUMAN; LUNG DISEASE; OCCUPATIONAL DISEASE; REVIEW;

ALGORITHMS; HUMANS; LUNG DISEASES; OCCUPATIONAL DISEASES;

EID: 0346929424     PISSN: 03002896     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0300-2896(15)30086-7     Document Type: Review

References (139)

1. Seaton A. Diagnosing and managing occupational disease. Br Med J 1995; 310: 1282.
2. Bernaldo de Quirós C, Rego G, Martínez C, Quero A, Bustillo F, Eguidazu JL et al. Pneumoconiosis in slate workers. Eur Respir J 1993; 6: 349s.
3. Martínez C, Quero A, Bernaldo de Quirós C, Obrero IG, Díaz A. Datos preliminares del estudio epidemiológico en la industria del granito en la comunidad autónoma de Extremadura. Arch Bronconeumol 1993; 29: S53.
4. Kogevinas M, Antó JM, Soriano JN, Tobias A, Burney P. The risk of asthma attribuible to occupational exposures. A population based study in Spain. Am J Crit Care Med 1996; 154: 137-143.
5. Ross DJ. Ten years of the SWORD projet: surveillance of the work-related and occupational respiratory disease. Clin Exp Allergy 1999; 29: 750-753.
6. Meredith S, Nordman H. Occupational asthma: measures of frequency from four countries. Thorax 1996; 51: 435-440.
7. Hoar SK, Morrison AS, Cole P, Silverman DT. An occupational linkage system for the study of occupational carcinogens. J Occup Med 1980; 22: 722-726.
8. Rosensenstock L, Logerfo J, Heyer NJ, Carter W. Development and validation of a self-administered occupational health history questionnaire. J Occup Med 1984; 26: 50-54.
9. Steward PA, Steward WF, Siemiatycki J, Heineman EF, Dosemecini M. Questionnaires for collecting detailed occupational information for community-based case-control studies. Am Ind Hyg Assoc J 1998; 58: 39-44.
10. Husgafvel-Pursiainen K, Ridanpaa M, Anttila S, Vainio H. p53 and ras gene mutation in lung cancer: implications for smoking and occupational exposures. J Occup Environ Med 1995; 37: 69-76.
11. National Research Council (NRC) and Committee on Risk Assessment of Hazardous Air Pollutants. National Research Council (NRC), Committee on Risk Assessment of Hazardous Air Pollutants, editores. Science and Judgment in Risk Assessment. Washington, DC: National Academy Press, 1994.
12. Monographs on the Evaluation of Carcinogenic Risk of Chemicals to Man. Ginebra: World Health Organization, International Agency for Research on Cancer (IARC). IARC International Agency for Research on Cancer, 1972; 1.
13. American Conference of Governmental Industrial Hygienists (ACGIH). Threshold Limit Values for Chemical Substances and Physical Agents, and Biological Exposure Indices (1996-1997). Cincinnati: ACGIH, 1996.
14. UNE-EN 689. Atmósferas en el lugar de trabajo. Directrices para la evaluación de la exposición por inhalación de agentes químicos para la comparación con los valores límite y estrategia de la medición. AENOR, 1996.
15. Medical Research Council's Committee on the Aetiology of Chronic Bronchitis (1960). Standardized questionnaires on respiratory symtoms. Fletcher CM (Chairman), Clifton M, Fairbairn AS, Fry J, Gilson JC, Higgins ITT, Mair A, Pemberton J, Rogan JM, Smith DH y Wood CH (Secretary). Br Med J 1960; 2: 1665.
16. Epidemiology standardization project, executive committee, American Thoracic Society. Recommended respiratory disease questionnaires for use with adults and children in epidemiological research. Am Rev Respir Dis 1978; 118: 7-52.
17. Miette A. Questionnaire of the European Community for Coal and Steel (ECSC) on respiratory symptoms. Eur Respir J 1989; 2: 165-177.
18. Burney PGJ, Chinn S, Britton JR, Tattersfield AE, Papacosta AO. What symtoms predict the bronchial response to histamine Evaluation in a community survey of the Bronchial Symptoms Questionnaire (1984) of The International Union Against Tuberculosis and Lung Disease. Eur J Respir Dis 1989; 18: 165-173.
19. Burney PGJ, Chinn S. Developing a new questionnaire for measuring the prevalence and distribution of asthma. Chest 1987; 91: S79-S83.
20. Marco R, Zanolin ME, Accordini S, Signorelli D, Marioni A, Bugiani M et al. A new questionnaire for the repeat of the first stage of the European Community Respiratory Health Survey: a pilot study. Eur Respir J 1999; 14: 1044-1048.
21. American Thoracic Society. Standadization of Spirometry. 1994 Update. Am J Respir Crit Care Med 1995; 152: 1107-1136.
22. Standardized Lung Function Testing. Official Statement of the European Respiratory Society. Eur Respir J 1993; 6 (Supl 16): 1-100.
23. Recomendaciones de la Sociedad Española de Neumología y Cirugía Torácica (SEPAR). Normativa para espirometría forzada. Barcelona: Doyma, 1985.
24. Roca J, Sanchís J, Agustí-Vidal A, Rodríguez Roisin R. Spirometric reference values for a mediterranean population. Bull Eur Physiopathol Respir 986; 22: 217-224.
25. Padley S, Gleeson F, Flower CDR. Review article: current indications for high resolution computed tomography scanning of the lungs. Br J Radiol 1995; 68: 105-109.
26. Zerhouni E. Computed tomography of the pulmonary parenchyma. Chest 1989; 95: 901-907.
27. Funahashi A, Schlueter DP, Pintar K, Siegesmund KA. Value of m situ elemental microanalysis in the histologic diagnosis of silicosis. Chest 1984; 85: 506-509.
28. Mahler DA, Weinberg DH, Wells CK, Feinstein AR. The measurement of dyspnea. Chest 1984; 85: 751-758.
29. Stervus SS, Galunter EH. A ratio scales and category scales for a dozen perceptual continua. J Exp Psychol 1957; 54: 377-411.
30. Jones PW, Quirk FH, Baveystock CM. The St George's Respiratory Questionnaire. Respir Med 1991; 85 (Supl B): 25-31.
31. Guyatt GH, Berman LB, Towsend M et al. A mesure of quality of life for clinical trials in chronic lung disease. Thorax 1987; 42: 773-778.
32. American Thoracic Society. Evaluation of impairment/disability secondary to respiratory disorders. Am Rev Respir Dis 1986; 133: 1205-1209.
33. Siafakas NM, Vermeire P, Pride NB, Paoletti P, Gibson J, Howard P et al. Optimal assessment and management of obstructive pulmonary disease (COPD). A consensus statement of the European Respiratory Society (ERS). Eur Respir J 1995; 8: 1398-1420.
34. Ruwbone RG. Future impact of genetic screening in occupational and environmental medicine. Occup Environ Med 1999; 56: 721-724.
35. Schulte PA, Lomax GP, Ward EM, Colligan MJ. Ethical issues in the use of genetic markers in occupational epidemiologic research. JOEM 1999; 41: 639-645.
36. Cullen MR, Cherniac MC, Rosenstock L. Occupational medicine. N Engl J Med 1990; 322: 594-601.
37. Davis GS. Pathogenesis of silicosis: current concepts and hypotheses. Lung 1986; 164: 139-154.
38. Brooke T, Churg M, Churg A. Mechanisms in the pathogenesis of asbestosis and silicosis. Am Rev Respir Crit Care Med 1998; 157: 1680-1698.
39. Schins R, Borm P. Mechanisms and mediators in coal dust induced toxicity: a review. Ann Occup Hyg 1999; 43: 7-33.
40. Janssen YM, Heintz NH, Mossman BT. Induction of c-fos and c-jun proto-oncogene expresion by asbestos is ameliorated by N-acetyl-cysteine in mesothclial cells. Cancer Res 1995; 55: 2085-2089.
41. Hitado J, Escribano D, Roman A, Méndez A, Mosquera JA. Lesiones pleuropulmonares en las enfermedades reumáticas. Repercusión sobre la neumoconiosis del carbón. Rev Esp Reumatol 1979; 6: 187-237.
42. Gernez-Rieux D, Tracquet A, Devulder B, Voisin C, Tonnel A, Aerts C et al. Experimental study of interactions between pneumoconiosis and mycobacterial infection. Ann NY Acad Sci 1972; 200: 106-126.
43. Snider D. The relationship between tuberculosis and silicosis. Am Rev Respir Dis, 1978; 118: 455-460
44. Suratt PM, Winn WC Jr, Brody AR, Bolton WK, Giles RD. Acute silicosis in tombstone sandblasters. Am Rev Respir Dis 1977; 115: 521-529.
45. Seaton A, Legge JS, Henderson J, Kerr KM. Accelerated silicosis in Scottish stonemasons. Lancet 1991; 337: 341-344.
46. Rego Fernández G, Piñeiro Amigo L, Rodríguez Menéndez MC, Rodríguez Pandiella J. Silicosis acelerada en un trabajador de cameras de granito. Medicina del Trabajo 1997; 6: 215-226.
47. International Labour Office Guidelines for the use of ILO international classification of radiographs of pneumoconioses. Ginebra: International Labour Office, 1980.
48. Wouters EFM, Jorna THJM, Westenend M. Respiratory effects of coal dust exposure: clinical effects and diasnosis. Experimental Lung Research 1994; 20: 385-394.
49. Fernández Rego G, Cuervo Gonzalez JV, Isidro Montes I, Martínez González C, Quero Martínez A, Bernaldo de Quirós García C. Diagnóstico de neumoconiosis simple con la referencia de la Clasificación Internacional (ILO-80). Problemas que persisten. Medicina y Seguridad del Trabajo 1995; 42: 3-8.
50. Bégin G, Ostiguy G, Fillion R, Colman N. Computed tomography scan in the early detection of silicosis. Am Rev Respir Dis 1991; 144: 697-705.
51. Martínez C, Rego G, Jiménez JR. Valor de la tomografía computarizada en el diagnostico de la neumoconiosis complicada de mineros del carbón. Arch Bronconeumol 1997; 33: 12-15.
52. Blanco I, Miranda J, Motto A, F.-Bustillo E, Roman J, Canto H et al. Aportaciones de la tomografía axial computarizada al estudio de la neumoconiosis de los mincros del carbón en estadios precoces. Arch Bronconeumol 1993; 29: 274-280.
53. INS-Insalud. La silicosis. Oviedo: Gráficas Summa, 1987.
54. Wagner GR. Screening and surveillance of Workers exposed to mineral dusts. Ginebra: WHO, 1996.
55. American Thoracic Society. Adverse effects of crystalline silica exposure. Am J Respir Crit Care Med 1997; 155: 761-765.
56. Bernaldo de Quirós García C, Martínez González C, Quero Martínez A, Eguidazu Pujares JL. High risk of complicated pneumoconiosis in underground kaolin mines. Libro Actas Fifth International Conference on Environmental and Occupational Lung Disease. Orlando, Florida, 1995; 24.
57. Glover JR, Bevan C, Cotes JE, Elwood PC, Hodgen NG, Lowe CR et al. Effects of exposure to slate dust in North Wales. Br J Ind Med 1980; 37: 152-162.
58. Rego Fernández G, Martínez González C, Pérez Blanco MT, Palenciano Ballesteros L, Fernández Borque J. Prevalencia de neumoconiosis y su relación con la función pulmonar en trabajadores de pizarras. Arch Bronconeumol 1999; 35 (Supl): 113.
59. Abraham JL. Lung pthology in 22 cases of giant cell interstitial pneumonia (GIP) suggest GIP is pathonogmonic of cobalt (hard metal) disease. Chest 1987; 91: 312A.
60. Rossman MD, Kern JA, Elias JA, Gullen MR, Epstein PE, Preuss OP et al. Proliferative response of bronchoalveolar lymphocytes to beryllium. Ann Intern Med 1988; 108: 687-693.
61. Michell J, Manning GB, Molyneaux M. Pulmonary fibrosis in workes exposed to finely powdered aluminum. Br J Ind Med 1960; 139: 1042-1056.
62. Cugell DW, Morgan WKC, Perkins DG, Rubin A. The respiratory effects of cobalt. Arch Intern Med 1990; 150: 177-183.
63. Villar TG. Vineyard sprayer's lung. Am Rev Respir Dis 1974; 110: 545-555.
64. Chen WJ, Monnat R, Chen M, Karle-Mottet N. Aluminum induced pulmonary granulomatosis. Hum Pathol 1978; 9: 705-711.
65. Bost TW, Newman S. Metal-induced interstitial lung diseases: a clinicopathologic approach. Semin Respir Med 19934; 14: 197-211.
66. Meredith SK, Taylor VM, McDonald JC. Occupational respiratory disease in the United Kingdon, 1989: a report to the British Thoracic Society and the Society of Occupational Medicine by the SWORD project group. Br J Ind Med 1991; 48: 292-298
67. Magnani C, Terracini B. A cohort study on mortality among wives of workers in the asbestos cement industry in Casale Monferrato. Italy. Br J Ind Med 1993; 59: 779-784.
68. Cordier S, Lazar P, Brochard P, Brignon J, Ameille J. Epidemiologie investigation of respiratory effects related to environmental exposure to asbestos inside insulated buildings. Arch Environ Health 1987; 42: 303-309.
69. Kamp DW, Weithman SA. The molecular basis of asbestos induced lung injury. Thorax 1999; 54: 638-652.
70. Jones RN. The diagnosis of asbestosis. Am Rev Respir Dis 1991; 144: 477-478.
71. American Thoracic Society. The diagnosis of nonmalignant diseases related to asbestos. Am Rev Respir Dis 1986; 134: 363-368.
72. Gaensler EA, Jerderlinic PJ, Churg A. Idiopathic pulmonary fibrosis in asbestos-exposed workers. Am Rev Respir Dis 1991; 144: 689-696.
73. Bégin R, Ostiguy G, Filion R, Colman N, Bertrand P. Computed tomography in early detection of asbestosis. Am J Ind Med 1985; 50: 689-698.
74. Costabel U, Donner CF, Haslam PL et al. Clinical role of BAL in occupational diseases due to mineral dust exposure. Eur Respir Rev 1992; 8: 89-96.
75. Bégin R. Asbestos-related diseases. Eur Respir Mon 1999; 11: 158-177.
76. Beckett WS. Occupational respiratory diseases. N Engl J Med 2000; 342: 406-413.
77. Oxman AD, Muir DCF, Shannon HS, Stock SR, Hnizdo E, Lange HJ. Occupational dust exposure and chronic pulmonary disease: a systematic overview of the evidence. Am Rew Respir Dis 1993; 148: 38-48.
78. Soutar C, Campbell S, Gurr D, Lloyd M, Love R, Cowie H et al. Important deficits of lung function in three modern collery populations. Relation with dust exposure. Am Rev Respir Dis 1993, 147: 797-803.
79. Churg A. Small airways disease associated with mineral dust exposure. Semin Respir Med 1992; 13: 140-148.
80. Ruckley VA, Gauld SJ, Chapman JS, Davis JMG, Douglas AN, Fernie JM et al. Emphysema and dust exposure in a group of coal workers. Am Rev Respir Dis 1984; 129: 528-532.
81. American Thoracic Society. Adverse effects of crystaline silica exposure. Am J Respir crit Care Med 1987; 155: 761-765.
82. Hnizdo E, Murray J. Risk of pulmonary tuberculosis relative to silicosis and exposure to silica dust in South African gold miners. Occup Environ Med 1998; 55: 496-502.
83. Pelmear PL, Roos JO, Maehle WM. Occupationally induced scleroderma. J Occup Med 1992; 34: 20-25.
84. Jones RN, Turner-Warwick M, Ziskind M, Weill H. High prevalence of antinuclear antibodies in sandblasters silicosis. Am Rev Respir Dis 1976; 113: 393-395.
85. Churg A. Small airways disease associated with mineral dust exposure. Semin Respir Med 1992; 13: 140-148.
86. a ed.). St Louis: Mosby, 1996; 293-321.
87. Epler GR, McLond TC, Gaensler FA. Prevalence and incidence of benign asbestos pleural effusion in a working population. JAMA 1982; 247: 617-622.
88. Nicholson WJ, Perkel G, Selikoff IJ. Occupational exposure to asbestos: population at risk and projected mortality: 1980-2030. Am J Ind Med 1982; 3: 259-311.
89. Fink JN. Hypersensitivity pneumonitis. Chest 1992; 13: 303-309.
90. Selman M, Chapela R, Rashu G. Hypersensitivity pneumonitis. Seminars Respir Med 1993; 14: 350-363.
91. Sala J, Martínez C. Alveolitis alergica por exposición a polvo de isocianato. Arch Bronconeumol 1984; 20: 123-125.
92. Orriols R, Manresa JM, Aliaga JL, Codina R, Rodrigo MJ, Morell F. Mollusk shell hypersensitivity pneumonitis. Ann Intern Med 1990; 113: 80-81.
93. Quirce S, Hinojosa M, Blanco R, Cespon C, Yoldi M. Aspergillus fumigatus is the causative agent of hypersesitivity pneumonitis caused by esparto dust. J Allergy Clin Inmunol 1998; 102: 147-148.
94. Morell F, Gómez F, Uresandi F, González A, Suárez I, Rodrigo MJ. Espartosis. Un nuevo tipo de alveolitis. Med Clin (Barc) 1995; 105: 19-23.
95. Barranco P, Moreno-Ancillo A, Muñoz ML, Álvarez-Sala R, Gómez de Terreros L, Martín-Esteban M et al. Hypersensitivity pneumonitis in a worker exposed to tiger nut dust. J Allergy Clin Immunol 1999; 104: 500-501.
96. Meredith SK, McDonald JC. Work-related respiratory disease in the United Kingdom, 1989-1992: report on the SWORD project. Occup Med 1994; 44: 183-189.
97. Reynolds HY, Fulmer J, Kazmierowski J, Roberts W, Crystal RG. Analysis of cellular and protein content of broncoalveolar lavage fluid from patients with idiopathic pulmonary fibrosis and chronic hypersensitivity pneumonitis. J Clin Invest 1997; 59: 165-175.
98. Rose C, King T. Controversies in hypersensitivity pneumonitis. Am Rev Respir Dis 1992; 145: 1.
99. Coombs R, Gell P, Laehman P. The classification of allergic reactions underlying disease. Clinical aspects of immunology. Oxford: Blackwell, 1962.
100. Kawanami O, Basset F, Barrios R, Lacronique J Crystal RG. Hypersensitivity pneumonitis in man: light and electron microscopic studies of 18 lung biopsies. Am J Pathol 1983; 110: 275-289.
101. Fink JN. Diagnosis of hypersesitivity pneumonitis: the use of bronchoprovocation in the diagnosis of hypersesitivity pneumonitis. J Allergy Clin Inmunol 1979; 64: 590-591.
102. Morell F, Curull V, Orriols R, De Gracia J. Skin test in bird breeders disease. Thorax 1986; 41: 538-541.
103. Reynolds HY, Fulmer J, Kazmierowski J, Roberts W, Crystal RG. Analysis of cellular and protein content of broncoalveolar lavage fluid from patients with idiopathic pulmonary fibrosis and chronic hypersensitivity pneumonitis. J Clin Invest 1997; 59: 165-175.
104. Terho E. Diagnostic criteria for farmer's lung disease. Am J Ind Med 1986; 10: 329-334.
105. Hendrick DJ, Marshall R, Faux JA, Krall JM. Positive alveolar responses to antigen inhalation provocation test: their validity and recognition. Thorax 1980; 35: 415-17.
106. Barrowcliff DF, Arblaster PG. Farmers lung: a study of an early acute fatal case. Thorax 1968; 23: 490.
107. Kokkarinen JI, Tukiainen HO, Terho EO. Effect of corticosteroid treatment on the recovery of pulmonary function in farmer's lung. Am Rev Respir Dis 1992; 145: 3-9.
108. Bourke SJ, Banham SW, Carter R. Longuitudinal course of extrinsic allergic alveolitis in pigeon breeders. Thorax 1989; 44: 415-418.
109. Salvaggio JE. Recent advances in pathogenesis of allergic alveolitis. Clin Exp Allergy 1990; 20: 137-144.
110. A.T.S. Conference. Respiratory health hazards in agriculture. Am J Respir Crit Care Med 1998; 158: S31-S37.
111. Ross J, Seaton A, Morgan WK. Toxic gases and fumes. En: Morgan WK, Seaton A, editores. Occupational lung diseases. Filadelfia: WD Saunders, 1995.
112. Romero S, Hernández L, Gil J, Aranda I, Martín C, Sánchez-Payá J. Organizing pneumonia in textile printing workers: a clinical description. Eur Respir J 1998; 11: 265-271.
113. Cullen MR, Balmes JR, Robins JM, Smith GJW. Lipoid pneumonia caused by oil mist exposure in a steel rolling tandem mill. Am J Ind Med 1981; 2: 51-58.
114. Health and Safety Commision. Anual Report 1991/2. Londres: HMSO, 1992.
115. Perkner JJ, Fennelly KP, Balkisoon R, Bartelson BB, Ruttenber AJ, Wood RP et al. Irritant-associated vocal cord dysfunction. J Occup Environ Med 1998; 40: 136-143.
116. International Agency for Research on Cancer. IARC Monographs on the Evaluation of the Carcinogenic Risk of Chemicals to Humans. Re-evaluation of some Industrial Chemicals. Vol. 71. Lyon: IARC, 1999.
117. Simonato L. Lung cancer risk associated with occupational exposure. Eur Respir Mon 1999; II: 347-355.
118. Simonato L. Lung cancer risk associated with occupational exposure. Eur Respir Mon 1999; 11: 347-355.
119. Himoven A, Saarikoski ST, Linnainmaa K et al. Glutathione S-transferase and N-acetyltransferase genotypes and asbestos-associated pulmonary disorders. J Natl Cancer Inst 1996; 88: 1853-1856.
120. Peto J, Hodgson J, Matthews FE, Jones JR. Continuing increase in mesothelioma mortality in Britain. Lancet 12995; 345: 544-547.
121. Contreras GR, Rousseau R, Chang-Yeung M. Occupational respiratory diseases in British Columbia, Canada in 1991. Occup Environ Med 1994; 51: 710-712.
122. Blank P. Occupational asthma in a national disability survey. Chest 1987; 92: 613-617.
123. Bernstein IL, Chan-Yeung M, Malo JL, Bernstein DI, editores. Definition and classification of asthma. En: Asthma in the Workplace. Nueva York: Marcel Dekker, 1993; 1-4.
124. Chan-Yeung M, Malo JL. Aetiologic agents in occupational asthma. Eur Respir J 1994; 7: 346-371.
125. Burrows B. Association of asthma with serum IgE levels and skin test reactivity to allergens. N Engl J Med 1989; 320: 271-277.
126. Karol MH, Tollerud DJ, Campbell TP, Fabbri L, Maestrelli P, Saetta M et al. Predictive value of airways hyperresponsiveness and circulating IgE for identifying types of responses to toluene diisocyanate inhalation challenge. Am J Respir Crit Care Med 1994; 149: 611-615.
127. Tee RD, Cullinan P, Welche J, Burge PS, Newman Taylor AJ. Specific IgE to isocianates: a useful diagnostic role in occupational asthma. J Allergy Clin Inmunol 1998; 101: 709-711.
128. Frew A, Chang JH, Chang H, Quirce S, Noertjojo K, Keown P et al. T-lymphocyte to plicatic acid-human serum albumin conjugate in occupational asthma caused by western red cedar. J Allergy Clin Immunol 1998; 101: 841-847.
129. Humbert M, Grant JA, Taborda-Barata L, Durham SR. Pfister R, Menz G et al. High affinity IgE receptor (FceRI)-bearing cells in bronchial biopsies from atopic and nonatopic asthma. Am J Respir Crit Care Med 1996; 153: 1931-1937.
130. Kay AB. T-cells as orchestrators of the asthmatic response. Ciba Found Symp 1997; 206: 56-67.
131. Brooks MS, Hammad Y, Richards I, Giovinco-Barbas J, Jenkins K. The spectrum of irritant induced asthma. Chest 1998; 113: 42-49.
132. Leroyer C, PerfettiL, Cartier A, Malo JL. Can reactive airways dysfunction syndrome (DADS) transform into occupational asthma due to "sensitisation" to isocyanates? Thorax 1998; 53: 152-153.
133. Kipen HW, Blume R, Hutt D. Asthma experience in occupational and enviromental medicine clinic: low dose reactive airway disfunction syndrome. J Occup Med 1994; 36: 1133-1137.
134. Chan-Yeung M, Malo JL. Natural history of occupational asthma. En: Bernstein DI, editores. Asthma in the Workplace. Nueva York: Marcel Dekker, 1993; 199-322.
135. Siracusa A, Kennedy SM, ByBuncio A, Lin FJ, Marabini A, Chan-Yeung M. Prevalence and predictors of asthma in working groups in British Columbia. Am J Ind Med 1995; 28: 411-423.
136. Malo JL, Ghezzo H, L'Archevêque J, Lagier F, Perrin B, Cartier A. Is the clinical history a satisfactory means of diagnosing occupational asthma? Am Rev Respir Dis 1991; 143: 528-532.
137. Burge PS. Single and serial measurements of lung function in the diagnosis of occupational asthma. Eur J Respir Dis 1982; 63 (Supl 123): 47-59.
138. Chan-Yeung M. Assesment of asthma in the workplace: ACCP consensus statement. Chest 1995; 108: 1084-1117.
139. American Thoracic Society. Ad Hoc committee on impairment/ disability evaluation in subjets with asthma. Guidelines for evaluation of impairment/disability in patients with asthma. Am Rev Respir Dis 1993; 147: 1056-1061.